522 related articles for article (PubMed ID: 18177533)
41. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
Ma SK; Wu LY; Sun YC; Li B; Zhang HT
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
[TBL] [Abstract][Full Text] [Related]
42. Squamous cell carcinoma of the external auditory canal. Therapeutic prognosis based on a proposed staging system.
Austin JR; Stewart KL; Fawzi N
Arch Otolaryngol Head Neck Surg; 1994 Nov; 120(11):1228-32. PubMed ID: 7917206
[TBL] [Abstract][Full Text] [Related]
43. Guidelines for treating temporal bone carcinoma based on long-term outcomes.
Bacciu A; Clemente IA; Piccirillo E; Ferrari S; Sanna M
Otol Neurotol; 2013 Jul; 34(5):898-907. PubMed ID: 23507994
[TBL] [Abstract][Full Text] [Related]
44. Advanced squamous cell carcinoma of the base of the tongue treated with surgery and post-operative radiotherapy.
Tiwari RM; van Ardenne A; Leemans CR; Quak JJ; Tobi H; Mehta DM; Snow GB
Eur J Surg Oncol; 2000 Sep; 26(6):556-60. PubMed ID: 11034805
[TBL] [Abstract][Full Text] [Related]
45. Head and neck mucosal squamous cell carcinoma: results of palliative management.
Timon C; Reilly K
J Laryngol Otol; 2006 May; 120(5):389-92. PubMed ID: 16696879
[TBL] [Abstract][Full Text] [Related]
46. Size does matter: can we reduce the radiotherapy field size for selected cases of anal canal cancer undergoing chemoradiation?
Crowley C; Winship AZ; Hawkins MA; Morris SL; Leslie MD
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):376-9. PubMed ID: 19282157
[TBL] [Abstract][Full Text] [Related]
47. Middle ear cancer: a population-based study.
Gurgel RK; Karnell LH; Hansen MR
Laryngoscope; 2009 Oct; 119(10):1913-7. PubMed ID: 19373882
[TBL] [Abstract][Full Text] [Related]
48. Radiotherapy for squamous cell carcinoma of the nasal vestibule.
Wallace A; Morris CG; Kirwan J; Amdur RJ; Werning JW; Mendenhall WM
Am J Clin Oncol; 2007 Dec; 30(6):612-6. PubMed ID: 18091056
[TBL] [Abstract][Full Text] [Related]
49. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
50. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
[TBL] [Abstract][Full Text] [Related]
51. Factors associated with recurrence of squamous cell carcinoma involving the temporal bone.
McRackan TR; Fang TY; Pelosi S; Rivas A; Dietrich MS; Wanna GB; Labadie RF; Haynes DS; Bennett ML
Ann Otol Rhinol Laryngol; 2014 Apr; 123(4):235-9. PubMed ID: 24671478
[TBL] [Abstract][Full Text] [Related]
52. Chondrosarcomas of the skull base and temporal bone.
Lustig LR; Sciubba J; Holliday MJ
J Laryngol Otol; 2007 Aug; 121(8):725-35. PubMed ID: 17319989
[TBL] [Abstract][Full Text] [Related]
53. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
54. Mortality and causes of death after multimodality treatment for advanced oral and oropharyngeal cancer.
Wutzl A; Ploder O; Kermer C; Millesi W; Ewers R; Klug C
J Oral Maxillofac Surg; 2007 Feb; 65(2):255-60. PubMed ID: 17236930
[TBL] [Abstract][Full Text] [Related]
55. Post-treatment complications of soft tissue tumours.
Shapeero LG; De Visschere PJ; Verstraete KL; Poffyn B; Forsyth R; Sys G; Uyttendaele D
Eur J Radiol; 2009 Feb; 69(2):209-21. PubMed ID: 19101106
[TBL] [Abstract][Full Text] [Related]
56. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
[TBL] [Abstract][Full Text] [Related]
57. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
[TBL] [Abstract][Full Text] [Related]
58. Conservative management of vestibular schwannomas - second review of a prospective longitudinal study.
Raut VV; Walsh RM; Bath AP; Bance ML; Guha A; Tator CH; Rutka JA
Clin Otolaryngol Allied Sci; 2004 Oct; 29(5):505-14. PubMed ID: 15373864
[TBL] [Abstract][Full Text] [Related]
59. Combined therapy for carcinoma of the nasopharynx: a report of 49 cases.
Sheng H; Jia H
J Laryngol Otol; 1993 Mar; 107(3):201-4. PubMed ID: 8509695
[TBL] [Abstract][Full Text] [Related]
60. Embryonal rhabdomyosarcoma of the temporal bone.
Viswanatha B
Ear Nose Throat J; 2007 Apr; 86(4):218, 220-2. PubMed ID: 17500393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
